Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) have earned an average recommendation of “Hold” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating on the […]
27 Mar 06:16 · The Cerbat Gem